324 related articles for article (PubMed ID: 30599775)
1. c-MYB and DMTF1 in Cancer.
Fry EA; Inoue K
Cancer Invest; 2019; 37(1):46-65. PubMed ID: 30599775
[TBL] [Abstract][Full Text] [Related]
2. Targeting the transcription factor Myb by small-molecule inhibitors.
Uttarkar S; Frampton J; Klempnauer KH
Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor MYB as Therapeutic Target: Current Developments.
Klempnauer KH
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542205
[TBL] [Abstract][Full Text] [Related]
4. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
5. Dmp1 and tumor suppression.
Inoue K; Mallakin A; Frazier DP
Oncogene; 2007 Jun; 26(30):4329-35. PubMed ID: 17237816
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction involving the dmp1 transcription factor and its alteration in human cancer.
Sugiyama T; Frazier DP; Taneja P; Kendig RD; Morgan RL; Matise LA; Lagedrost SJ; Inoue K
Clin Med Oncol; 2008; 2():209-19. PubMed ID: 21892281
[TBL] [Abstract][Full Text] [Related]
7. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
[TBL] [Abstract][Full Text] [Related]
8. MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
Zhai X; Wu Y; Zhang D; Li H; Chong T; Zhao J
J Bioenerg Biomembr; 2021 Apr; 53(2):191-202. PubMed ID: 33686550
[TBL] [Abstract][Full Text] [Related]
9. Identification and regulation of c-Myb target genes in MCF-7 cells.
Quintana AM; Liu F; O'Rourke JP; Ness SA
BMC Cancer; 2011 Jan; 11():30. PubMed ID: 21261996
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin sensitivity in breast cancer cells is associated with particular DMTF1 splice variant expression.
Niklaus NJ; Humbert M; Tschan MP
Biochem Biophys Res Commun; 2018 Sep; 503(4):2800-2806. PubMed ID: 30100063
[TBL] [Abstract][Full Text] [Related]
11. ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.
Mertz JA; Kobayashi R; Dudley JP
J Virol; 2007 Apr; 81(7):3503-13. PubMed ID: 17229714
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesis.
Kovach AE; Zerkalenkova E; Zemtsova L; Borkovskaya A; Gaskova M; Kazanov M; Popov A; Baidun L; Maschan M; Maschan A; Gaynon PS; Bhojwani D; Novichkova G; Olshanskaya Y; Raca G
Cancer Genet; 2022 Jan; 260-261():37-40. PubMed ID: 34915342
[TBL] [Abstract][Full Text] [Related]
13. Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.
Pieraccioli M; Imbastari F; Antonov A; Melino G; Raschellà G
Cell Cycle; 2013 Jul; 12(14):2309-20. PubMed ID: 24067373
[TBL] [Abstract][Full Text] [Related]
14. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
15. MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma.
Xu LH; Zhao F; Yang WW; Chen CW; Du ZH; Fu M; Ge XY; Li SL
Int J Oncol; 2019 May; 54(5):1579-1590. PubMed ID: 30896785
[TBL] [Abstract][Full Text] [Related]
16. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
Uttarkar S; Dassé E; Coulibaly A; Steinmann S; Jakobs A; Schomburg C; Trentmann A; Jose J; Schlenke P; Berdel WE; Schmidt TJ; Müller-Tidow C; Frampton J; Klempnauer KH
Blood; 2016 Mar; 127(9):1173-82. PubMed ID: 26631113
[TBL] [Abstract][Full Text] [Related]
17. HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.
Nicot C; Mahieux R; Opavsky R; Cereseto A; Wolff L; Brady JN; Franchini G
Oncogene; 2000 Apr; 19(17):2155-64. PubMed ID: 10815807
[TBL] [Abstract][Full Text] [Related]
18. Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb.
Melotti P; Calabretta B
Blood; 1996 Mar; 87(6):2221-34. PubMed ID: 8630382
[TBL] [Abstract][Full Text] [Related]
19. Regulation of MYB by distal enhancer elements in human myeloid leukemia.
Li M; Jiang P; Cheng K; Zhang Z; Lan S; Li X; Zhao L; Wang Y; Wang X; Chen J; Ji T; Han B; Zhang J
Cell Death Dis; 2021 Feb; 12(2):223. PubMed ID: 33637692
[TBL] [Abstract][Full Text] [Related]
20. Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants.
Quelen C; Lippert E; Struski S; Demur C; Soler G; Prade N; Delabesse E; Broccardo C; Dastugue N; Mahon FX; Brousset P
Blood; 2011 May; 117(21):5719-22. PubMed ID: 21474671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
